# Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen

> **NCT06925906** · — · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Abdominal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06925906
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-05
- **Primary completion:** 2024-06-06
- **Final completion:** 2024-08-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06925906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06925906, "Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06925906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*